Senegal vs Zambia: Hepatitis B surface antigen (HBsAg) prevalence
Senegal
0.4%
in 2024
Zambia
0.4%
in 2024
Senegal rank
62nd
Zambia rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Senegal
- Zambia
How they compare
Senegal currently reports 0.4% against 0.4% in Zambia, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Senegal ahead.
Senegal ranks 62nd and Zambia ranks 62nd of 194 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Senegal | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 0.6% | 0.3% | Senegal |
| 2020s | 0.5% | 0.4% | 0.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Senegal or Zambia?
- Senegal, at 0.4% against 0.4% in Zambia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Senegal and Zambia?
- 0.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Zambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Senegal and Zambia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Senegal ranks 62nd and Zambia ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.